<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01152983</url>
  </required_header>
  <id_info>
    <org_study_id>CTIL - CL-001</org_study_id>
    <nct_id>NCT01152983</nct_id>
  </id_info>
  <brief_title>Safety and Performance Evaluation of the Rapid Ring Device</brief_title>
  <official_title>Single Center, Open Label, Prospective, Non-comparative, Non-randomized Study to Assess the Safety and Performance of the Rapid Ring Device (Comparative Study to Assess the Pain Reduction)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RapiDx Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RapiDx Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate the safety, performance and initial efficacy of
      the RapiDx device.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be a single center, open label, prospective, non-comparative, randomized trial
      and assess the safety and performance of the Rapid Ring device. In order to assess pain
      reduction, a comparative study will be performed and each subject will serve as his/her own
      control.

      Clinical assessment for all 100% patients will occur at baseline. All participants will be
      men and women above the age of 18. The trial will be conducted at a Medical Center.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>August 2010</start_date>
  <completion_date type="Anticipated">November 2010</completion_date>
  <primary_completion_date type="Anticipated">November 2010</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Collection of at least 2 drops (approximately 50microliter) of blood within one minute.</measure>
    <time_frame>approximately 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction in pain</measure>
    <time_frame>approximately 6 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Rapid Ring</intervention_name>
    <description>Rapid Ring is a ring-shaped device that encircles the distal phalanx of the middle finger and blocks the arterial blood to quickly and passively withdraw blood following a finger stick, and to reduce the pain of the lancet.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is healthy

          -  Subject's age is between 18 to 70 years old

          -  Subject must be capable of providing informed consent

        Exclusion Criteria:

          -  Clotting disorders

          -  Subject has a clinically significant untreated chronic disease which may unable him/
             her to participate in the study.

          -  Subject is taking anti-coagulant medication

          -  Non-intact finger tip (left middle/ring finger)

          -  Skin disease on the subject finger

          -  Abnormal blood pressure

          -  Pregnant or lactating women

          -  Menstrual period

          -  Previous diagnosis of HIV or Hepatitis

          -  Participation in other clinical investigations within previous 30 days

          -  Peripheral blood vessels diseases

          -  Diabetes

          -  Neuropathic pain
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ella Naparstek, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chairman of the Hematology Institute and the Department of Hematology and Bone Marrow Transplantation at Tel Aviv Sourasky Medical Center.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Boris Tartakovsky, PhD</last_name>
    <email>boris.tartakovsky@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tel-Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Boris Tartakovsky, PhD</last_name>
      <email>boris.tartakovsky@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ella Naparstek, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Boris Tartakovsky, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>June 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2010</study_first_submitted>
  <study_first_submitted_qc>June 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2010</study_first_posted>
  <last_update_submitted>June 28, 2010</last_update_submitted>
  <last_update_submitted_qc>June 28, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 29, 2010</last_update_posted>
  <responsible_party>
    <name_title>Erez Rozenfeld</name_title>
    <organization>RapiDx Ltd</organization>
  </responsible_party>
  <keyword>Finger sticks</keyword>
  <keyword>Rapid Ring</keyword>
  <keyword>Finger sticks method of obtaining blood for diagnostic testing</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

